Page last updated: 2024-11-04

vorinostat and Weight Gain

vorinostat has been researched along with Weight Gain in 1 studies

Vorinostat: A hydroxamic acid and anilide derivative that acts as a HISTONE DEACETYLASE inhibitor. It is used in the treatment of CUTANEOUS T-CELL LYMPHOMA and SEZARY SYNDROME.
vorinostat : A dicarboxylic acid diamide comprising suberic (octanedioic) acid coupled to aniline and hydroxylamine. A histone deacetylase inhibitor, it is marketed under the name Zolinza for the treatment of cutaneous T cell lymphoma (CTCL).

Weight Gain: Increase in BODY WEIGHT over existing weight.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kim, DW1
Park, JW1
Willingham, MC1
Cheng, SY1

Other Studies

1 other study available for vorinostat and Weight Gain

ArticleYear
A histone deacetylase inhibitor improves hypothyroidism caused by a TRĪ±1 mutant.
    Human molecular genetics, 2014, May-15, Volume: 23, Issue:10

    Topics: Adipogenesis; Animals; CCAAT-Enhancer-Binding Proteins; Drug Evaluation, Preclinical; Epigenesis, Ge

2014